1. Home
  2. AIMD vs AEHL Comparison

AIMD vs AEHL Comparison

Compare AIMD & AEHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIMD
  • AEHL
  • Stock Information
  • Founded
  • AIMD 1984
  • AEHL 1993
  • Country
  • AIMD United States
  • AEHL China
  • Employees
  • AIMD N/A
  • AEHL N/A
  • Industry
  • AIMD Biotechnology: Pharmaceutical Preparations
  • AEHL Building Materials
  • Sector
  • AIMD Health Care
  • AEHL Industrials
  • Exchange
  • AIMD Nasdaq
  • AEHL Nasdaq
  • Market Cap
  • AIMD 8.2M
  • AEHL 8.5M
  • IPO Year
  • AIMD N/A
  • AEHL 2007
  • Fundamental
  • Price
  • AIMD $0.51
  • AEHL $2.72
  • Analyst Decision
  • AIMD
  • AEHL
  • Analyst Count
  • AIMD 0
  • AEHL 0
  • Target Price
  • AIMD N/A
  • AEHL N/A
  • AVG Volume (30 Days)
  • AIMD 259.6K
  • AEHL 124.1K
  • Earning Date
  • AIMD 08-04-2025
  • AEHL 05-01-2025
  • Dividend Yield
  • AIMD N/A
  • AEHL N/A
  • EPS Growth
  • AIMD N/A
  • AEHL N/A
  • EPS
  • AIMD N/A
  • AEHL N/A
  • Revenue
  • AIMD $106,207.00
  • AEHL $98,773,000.00
  • Revenue This Year
  • AIMD N/A
  • AEHL N/A
  • Revenue Next Year
  • AIMD N/A
  • AEHL N/A
  • P/E Ratio
  • AIMD N/A
  • AEHL N/A
  • Revenue Growth
  • AIMD 13.38
  • AEHL 36.99
  • 52 Week Low
  • AIMD $0.40
  • AEHL $1.79
  • 52 Week High
  • AIMD $1.07
  • AEHL $256.40
  • Technical
  • Relative Strength Index (RSI)
  • AIMD 38.36
  • AEHL 53.14
  • Support Level
  • AIMD $0.49
  • AEHL $2.33
  • Resistance Level
  • AIMD $0.52
  • AEHL $2.75
  • Average True Range (ATR)
  • AIMD 0.05
  • AEHL 0.25
  • MACD
  • AIMD -0.01
  • AEHL 0.05
  • Stochastic Oscillator
  • AIMD 12.55
  • AEHL 69.70

About AIMD Ainos Inc.

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

About AEHL Antelope Enterprise Holdings Limited

Antelope Enterprise Holdings Ltd operates in two reportable operating segments: 1) business management consulting, information system technology consulting services including the sales of software use rights for digital data deposit platforms and asset management systems, and online social media platform development and consulting, and 2) natural gas power generation, which was in the initial development stage. The business of the Company is engaged in the PRC and U.S.

Share on Social Networks: